packageNilotinib

nilotinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nilotinib is a BCR-ABL tyrosine kinase inhibitor used to treat certain leukemias, notably chronic myelogenous leukemia that is BCR-ABL positive. It is authorised in the European Union and is an approved medicine, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q412327 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:nilotinib
ATC codes:L01EA03
DrugBank:DB04868
PubChem CID:644241
ChEBI:52172
Wikidata:Q412327
formula:C28H22F3N7O
molar mass:529.526 g/mol (PubChem CID 644241)
logP:4.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown